Skip to main content
INBIOGEN CO.,Ltd logo

INBIOGEN CO.,Ltd — Investor Relations & Filings

Ticker · 101140 ISIN · KR7101140002 KO Professional, scientific and technical activities
Open in API
Filings indexed 342 across all filing types
Latest filing 2022-01-06 Major Shareholding Noti…
Country KR South Korea
Listing KO 101140

About INBIOGEN CO.,Ltd

https://www.inbiogen.com/

INBIOGEN is a life sciences company that provides Virtual Biotech Assistance to international biotechnology companies, pharmaceutical firms, and research organizations. The company specializes in harnessing data mining to deliver a range of services, including bioinformatics, custom data curation, database development, and the creation of operational platforms. Core bioinformatics offerings encompass data analysis, protein modeling, homology searches, phylogeny, and immunogenicity analysis. Additionally, INBIOGEN provides virtual research, marketing assistance, and web development services. The company focuses on creating customized, value-added solutions through a team of experienced scientists and bioinformatics professionals to help clients address challenges and utilize online resources effectively.

Recent filings

Filing Released Lang Actions
임원ㆍ주요주주특정증권등소유상황보고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure when a major shareholder or executive changes their stake in a company. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider transactions and changes in significant shareholdings by company insiders or major shareholders.
2022-01-06 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed in South Korea under the Capital Markets Act. This type of filing is used to notify the market when a shareholder's stake in a company crosses a significant threshold (typically 5%). In the provided taxonomy, this corresponds to a 'Major Shareholding Notification'.
2022-01-06 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea (often referred to as a 5% rule filing). It details changes in share ownership, including disposals and adjustments to convertible bond conversion prices by a group of investors (Nomical Investment Association and special related parties). This fits the definition of a Major Shareholding Notification.
2022-01-05 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) filed by Inbiogen. This type of filing is a regulatory requirement in South Korea when a major shareholder's stake changes due to events like third-party capital increases. While it involves share ownership, it is specifically a notification of a major shareholder's change in status rather than a director's personal dealing (DIRS) or a general share issue announcement (SHA). Given the specific nature of reporting major shareholder ownership thresholds and changes, it falls under the Major Shareholding Notification category.
2021-12-30 Korean
유상증자또는주식관련사채등의발행결과(자율공시)
Share Issue/Capital Change Classification · 100% confidence The document is a formal regulatory filing from the Korea Exchange (KRX) regarding the 'Result of Issuance' for a capital increase (paid-in capital increase/third-party allocation). It details the number of shares issued, the amount raised, and the payment date. This falls under the category of share issuance and capital changes.
2021-12-29 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership (specifically the acquisition of convertible bonds) by a major shareholder, Bucket Studio, in the issuer, Inbiogen. This type of filing is a mandatory disclosure for significant shareholding changes and falls under the 'Major Shareholding Notification' category.
2021-12-27 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.